Sangui Biotech International (HAM:SBH) Scaled Net Operating Assets : -1.84 (As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Sangui Biotech International Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sangui Biotech International's operating assets for the quarter that ended in Mar. 2023 was €0.08 Mil. Sangui Biotech International's operating liabilities for the quarter that ended in Mar. 2023 was €0.25 Mil. Sangui Biotech International's Total Assets for the quarter that ended in Dec. 2022 was €0.09 Mil. Therefore, Sangui Biotech International's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2023 was -1.84.

Sangui Biotech International Scaled Net Operating Assets Historical Data

The historical data trend for Sangui Biotech International's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Scaled Net Operating Assets Chart

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Scaled Net Operating Assets

Get a 7-Day Free Trial

-1.31

-1.44

-0.64

-0.63

-0.86

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.61	-0.56	-0.86	-1.09	-1.84

Competitive Comparison of Sangui Biotech International's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sangui Biotech International's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's Scaled Net Operating Assets falls into.

Sangui Biotech International Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sangui Biotech International's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2022 )
=	(Operating Assets (A: Jun. 2022 )	-	Operating Liabilities (A: Jun. 2022 ))	/	Total Assets (A: Jun. 2021 )
=	(0.096	-	0.191)	/	0.111
=	-0.86

where

	Operating Assets		(A: Jun. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.124	-	0.028
=	0.096

	Operating Liabilities		(A: Jun. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.971	-	0.085	-	0.695
=	0.191

Sangui Biotech International's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2023 )
=	(Operating Assets (Q: Mar. 2023 )	-	Operating Liabilities (Q: Mar. 2023 ))	/	Total Assets (Q: Dec. 2022 )
=	(0.076	-	0.247)	/	0.093
=	-1.84

where

	Operating Assets		(Q: Mar. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.083	-	0.007
=	0.076

	Operating Liabilities		(Q: Mar. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.026	-	0.067	-	0.712
=	0.247

Sangui Biotech International Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (HAM:SBH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (HAM:SBH) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

SGBI:USA

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.